Aggressive natural killer cell leukemia/lymphoma (ANKL) is a rare and highly aggressive NK cell neoplasm with a short clinical course and poor prognosis and is often misdiagnosed and confused with NK/T cell lymphoma (NKTL), which has a very different prognosis. Here, we present a case with nasal and bone marrow involvement, provide a literature review and make a differential diagnosis.
A 41-year-old male presented nasal congestion pharyngalgia, palatal perforation, high fever and multiorgan dysfunction. Our diagnosis primarily relied on clinical features, the morphology and immunophenotype of the neoplastic cells and imaging studies. Characteristic large granular lymphocytes with azurophilic granules were visible in the bone marrow smears. In addition, the neoplastic cells expressed a typical immunophenotype, and the T cell receptor γ (TCR-γ) gene rearrangement analysis and presence of Epstein-Barr virus (EBV) were negative. The patient’s symptoms and signs were temporarily relieved after chemotherapy treatment, but after a short time, he underwent a rapid clinical decline and died 8 weeks later after admission due to multiorgan function failure.
Our case demonstrates that to avoid a misdiagnosis, bone marrow analyses and other examinations should be performed early when a patient initially presents nasal lesions and other systemic symptoms. To the best of our knowledge, this may be the first reported case of ANKL with sternal tenderness.
Fernandez LA, Pope B, Lee C, Zayed E. Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line. Blood. 1986;67(4):925–30. PubMed
Lima M. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis. Orphanet Journal of Rare Disease. 2013;8:95. CrossRef
Chan JKC, Jaffe ES, Ralfkiaer E, Ko YH. Aggressive NK-cell leukaemia. In: Swerdlow SH, editor. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: the International Agency for Research on Cancer press; 2008. p. 276–7.
Kwong YL. The diagnosis and management of extranodal NK/T cell lymphoma, nasal type and aggressive NK cell leukemia. J Clin Exp Hematopathol. 2011;51(1):21–8. CrossRef
Cheuk W, Chan JKC. NK-Cell Neoplasms. In: Jaffe ES, editor. Hematopathology. Lyon: Saunders/Elsevier; 2011. p. 473–91. CrossRef
Chang OS, Young HK. Bone marrow is involved in less than 10% of patients with nasal-type NK/T cell lymphoma at initial diagnosis. J Korean Med Sci. 2004;19:229–33. CrossRef
Stefania G, Alden M, Georg S, Luca M, Emanuele Z, Vittoria E. Extranodal NK/T-cell lymphoma with leukaemic presentation. Br J Haematol. 2013;161:754. CrossRef
Sherif AR. Huang Q: Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow. Int J Clin Exp Pathol. 2011;4(7):713–7.
- Aggressive natural killer cell leukemia or extranodal NK/T cell lymphoma? a case with nasal involvement
- BioMed Central
Neu im Fachgebiet Pathologie